Main Article Content

Наталья Николаевна Константинова
Вадим Гельевич Мозес
Светлана Ивановна Елгина
Елена Владимировна Рудаева
Кира Борисовна Мозес

Abstract

Thyroid lymphoma refers to rare forms of non-Hodgkin's extranodal lymphomas.
A characteristic feature of lymphoma in our cases was the rapid progression of symptoms of compression of the neck and mediastinum, which required immediate diagnosis and urgent initiation of treatment. Surgical intervention on the thyroid gland made it possible to stop life-threatening syndromes and made it possible to obtain material for morphological verification of the tumor. Specialized treatment made it possible to obtain stabilization in the first case, and remission in the second. Although this tumor is characterized by local spread and the development of localized recurrence, thyroid lymphoma belongs to an unfavorable prognostic group. According to literature data, the use of a combination of radiation and chemotherapy increases the overall effect of treatment compared with the use of chemotherapy alone or a combination of chemotherapy and surgical treatment. The use of radiation therapy in combination with chemotherapy reduces the likelihood of disease progression compared to other treatment options. Further experience in the treatment of such patients will make it possible to use a combination of radiation and chemotherapy in practice.

Keywords

thyroid gland, lymphoma, clinic, treatment

Author Biographies

Наталья Николаевна Константинова,
candidate of medical sciences, surgeon, endocrinologist, department of endocrine surgery
Вадим Гельевич Мозес,
doctor of medical sciences, professor, director of the Medical Institute
Светлана Ивановна Елгина,
doctor of medical sciences, docent, professor of department of obstetrics and gynecology N 1
Елена Владимировна Рудаева,
candidate of medical sciences, docent, docent of the department of obstetrics and gynecology named after G.A. Ushakova
Кира Борисовна Мозес,
assistant of the department of polyclinic therapy and nursing

Article Details

Information about financing and conflict of interests

The study had no sponsorship.
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.

How to Cite

Константинова, Н. Н., Мозес, В. Г., Елгина, С. И., Рудаева, Е. В., & Мозес, К. Б. (2022). CLINIC, DIAGNOSIS AND TREATMENT OF NON-HODGKIN’S LYMPHOMA OF THE THYROID GLAND. Medicine in Kuzbass, 21(4), 87-91. https://doi.org/10.24412/2687-0053-2022-4-87-91

References

Jaffe ES. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lion: IARC Press; Oxford: Oxford University Press, 2001

Magrath I. The non-Hodgkin’s lymphomas in children. In: Oxford Textbook of Oncology. Oxford Medical Publications, Oxford: 1995. P. 1809-1851

Magrath I. B-Cell Lymphoma/Burkitt Lymphoma. In: Pediatric. Lymphomas, ed. Berlin: 2007. P. 142-168

Murphy SB, Bowman WP, Abromowitch M, Mirro J, Ochs J, Rivera G, et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol. 1986; 4(12): 1732-1739. DOI: 10.1200/JCO.1986.4.12.1732

Elgina SI. The reproductive system of girls at the time of birth and prevention of violations of its development in the postnatal period: abstr. dis. ... doct. med. sciences. Omsk, 2009. 39 p. Russia (Елгина С.И. Репродуктивная система девочек на момент рождения и профилактика нарушений ее становления в постнатальном периоде: автореф. дис. … докт. мед. наук. Омск, 2009. 39 с.

Reiter A, Schrappe M, Parwaresch R, Henze G, Müller-Weihrich S, Sauter S, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage – a report of the Berlin-Frankfurt-Münster Group. J Clin Oncol. 1995; 13(2): 359-372. DOI: 10.1200/JCO.1995.13.2.359

Goldman S, Gerrard M, Sposto R, Davenport G, Aupérin A, Pinkerton R, et al. Exellent results in children and adolescents with isolated mature B-cell acute lymphoblastic leukemia (B-ALL) (Burkitt): Report from the FAB International LMB study FAB/LMB 96. Blood. 2005; 106: 234-234. DOI: 10.1182/BLOOD.V106.11.234.234

Atra A, Gerrard M, Hobson R, Imeson JD, Hann IM, Pinkerton CR. Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols. Br J Haematol. 2001; 112(4): 965-968. DOI: 10.1046/j.1365-2141.2001.02647.x

Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood. 1999; 94(10): 3294-3306

Samochatova EV, Maschan AA, Shelikhova LN, Myakova NV, Belogurova MB, Khlebnikova OP, et al. Therapy of advanced-stage mature B-cell lymphoma and leukemia in children and adolescents with rituximab and reduced intensity induction chemotherapy (B-NHL 2004M protocol): the results of a multicenter study. J Pediatr Hematol Oncol. 2014; 36(5): 395-401. DOI: 10.1097/MPH.0b013e31829d4900

Downloads

Download data is not yet available.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>